Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Buy Savient Pharmaceuticals For A Good Momentum Play
Seeking Alpha
Friday, August 24, 2012 - 11:17am
tags:
Savient
Discovery Labs rises as analyst forecasts $121 million in respiratory product sales by 2018
Yahoo/AP
Friday, August 24, 2012 - 11:17am
tags:
Discovery Labs, respiratory distress syndrome, Afectair, Surfaxin
Analyst projects Neptune sales will grow from $26 million during Fiscal 2013 to an estimated $75 million by Fiscal 2016
Yahoo/Reuters
Friday, August 24, 2012 - 11:15am
tags:
Neptune Technologies & Bioressources
Abbott’s Humira May Not Be Effective In Colitis, FDA Says
Bloomberg
Friday, August 24, 2012 - 11:12am
tags:
FDA, Abbott Laboratories, Humira, ulcerative colitis
Healthcare Business Review: Impax’s Promising Future, Regeneron’s Relationship With Sanofi
Wall St. Cheat Sheet
Friday, August 24, 2012 - 11:10am
tags:
Impax, Sanofi, Regeneron, Wright Medical
Eli Lilly mulls options for Alzheimer's candidate
Marketwatch
Friday, August 24, 2012 - 11:09am
tags:
Alzheimer's disease, Eli Lilly, solanezumab
3 Reasons Pfizer Should Partner With MannKind
Motley Fool
Friday, August 24, 2012 - 11:01am
tags:
Pfizer, MannKind, inhaled insulin, diabetes, Nektar, Afrezza, Exubera
PropThink: Previewing Gilead's 'Quad' Ahead of FDA Decision
Yahoo/Reuters
Friday, August 24, 2012 - 10:59am
tags:
FDA, Quad, HIV, Gilead
Bristol to take $1.8 billion charge on hepatitis C drug failure
Reuters
Friday, August 24, 2012 - 10:33am
tags:
Bristol-Myers Squibb, hepatitis C, BMS-986094
Analysts: Roche's armed antibody will help drive breast cancer drug sales
Fierce Biotech
Thursday, August 23, 2012 - 10:24am
tags:
Roche, breast cancer, T-DM1
Will 'gamifying' drug R&D win more than Facebook fans for Boehringer?
Fierce Pharma
Thursday, August 23, 2012 - 10:22am
tags:
social media, Facebook, Boehringer Ingelheim, R&D
Pfizer, Mylan unveil generic tie-up in Japan
Yahoo/AFP
Thursday, August 23, 2012 - 10:14am
tags:
Pfizer, Japan, Mylan, generics
Spectrum Still Won't Answer Relevant Questions About Fusilev Discounts
TheStreet.com
Thursday, August 23, 2012 - 10:11am
tags:
Spectrum Pharmaceuticals, Fusilev
India's pharma reps strike over corruption perceptions
Pharmalot
Thursday, August 23, 2012 - 10:10am
tags:
strike, India, drug reps
Gilead Sciences Will Continue To Grow
Seeking Alpha
Thursday, August 23, 2012 - 10:04am
tags:
Gilead
GlaxoSmithKline, J&J to start rheumatoid arthritis drug trial
Reuters
Thursday, August 23, 2012 - 10:02am
tags:
GSK, JNJ, rheumatoid arthritis, sirukumab
Sanofi Launches Sklice in the US
Yahoo/Zacks
Thursday, August 23, 2012 - 10:00am
tags:
Sanofi, Sklice, head lice, lice
Should Arena Hold Off On New Marketing And Supply Agreements?
Seeking Alpha
Thursday, August 23, 2012 - 9:59am
tags:
Belviq, Arena Pharmaceuticals, Eisai
XOMA Receives Orphan Drug Designation From U.S. Food & Drug Administration for Gevokizumab
Yahoo
Thursday, August 23, 2012 - 9:58am
tags:
Xoma, FDA, orphan drugs, gevokizumab, uveitis
How Do Oncologists Sort Through All the New Anticancer Drugs?
Forbes
Thursday, August 23, 2012 - 9:56am
tags:
oncologists, cancer, physicians

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.